Philadelphia University + Thomas Jefferson University
Sidney Kimmel Medical College
Department of Medicine

Falkner, Bonita

< Back

Profile

bxf106

Bonita Falkner, MD

Contact Dr. Falkner

833 Chestnut Street
Suite 700
Philadelphia, PA 19107

(215) 955-6550
(215) 955-5034 fax fax

Medical School

University of Minnesota - 1967

Residency

Philadelphia General Hospital

Fellowship

Thomas Jefferson University Hospital

Board Certification

Pediatric Nephrology
Pediatrics

Hospital Appointment

Thomas Jefferson University Hospital

Research Interests

Research interests include the genetic basis of essential hypertension, insulin resistance and obesity

Publications

Most Recent Peer-Reviewed Publications

  1. Changes in the 2017 Pediatric Hypertension Clinical Guidelines
  2. Neurocognitive Function in Children with Primary Hypertension after Initiation of Antihypertensive Therapy
  3. New Clinical Practice Guideline for the Management of High Blood Pressure in Children and Adolescents
  4. Clinical practice guideline for screening and management of high blood pressure in children and adolescents
  5. Fibroblast growth factor-23 is independently associated with cardiac mass in African-American adolescent males
  6. Does Potassium Deficiency Contribute to Hypertension in Children and Adolescents?
  7. Hypertension in chronic kidney disease
  8. Uremia induces adipose tissue inflammation and muscle mitochondrial dysfunction
  9. Neurocognitive Function in Children with Primary Hypertension
  10. Association of inflammation prior to kidney transplantation with post-transplant diabetes mellitus
  11. Is the SPRINT blood pressure treatment target of 120/80 mm Hg relevant for children?
  12. Cardiometabolic risks related to obesity severity in children and adolescents: A commentary
  13. Is there a bend in the upward trend of high blood pressure in childhood? A commentary on prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012
  14. Treatment-induced changes in plasma adiponectin do not reduce urinary albumin excretion in the diabetes prevention program cohort
  15. Adolescent and adult African Americans have similar metabolic dyslipidemia
  16. Recent clinical and translational advances in pediatric hypertension
  17. Right analysis-wrong conclusion: Obese youth with higher BP are at risk for target organ damage
  18. Adiponectin receptor and adiponectin signaling in human tissue among patients with end-stage renal disease
  19. Associations of cardiac structure with obesity, blood pressure, inflammation, and insulin resistance in african-american adolescents
  20. Understanding the power of perinatal events and metabolic status in childhood